Gilead Sciences Publishes 2023 ESG Impact Report

NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and achievements of the prior year.

In this year's report, you will see examples of Gilead's impact across four pillars:

• Innovating Scientific Solutions
• Advancing Health Equity and Access
• Empowering People and Communities
• Sustaining Our Shared Planet

Learn how we're advancing our vision to create a healthier world while benefiting our people, the communities we support and our planet.

https://www.gilead.com/-/media/files/pdfs/2023-Environmental-Social-Governance-Impact-Report.pdf

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: [email protected]

SOURCE: Gilead Sciences

You May Also Be Interested In

• CASI Pharmaceuticals Announces First Half 2026 Business and Financial Results
• The Harvest Table to Participate in ECRM Vitamin, Weight Management & Sports Nutrition Session
• Engine Capital Urges H.B. Fuller’s Board of Directors to Run a Market Check for the Building Adhesive Solutions Segment and the Entire Company